Table 1.
Effects of varying SOX10 and EDNRB dosage on hypopigmentation
| Severity of Hypopigmentation | ||||||
|---|---|---|---|---|---|---|
| Genotype | No. | I | II | III | IV | V |
| Tg(Dct-Sox10)/+CF1-10 | 20 | 100% | 0 | 0 | 0 | 0 |
| Tg(Dct-Sox10)/+2272 | 17 | 100% | 0 | 0 | 0 | 0 |
| Tg(Dct-Sox10)/+2245 | 8 | 100% | 0 | 0 | 0 | 0 |
| Tg(Dct-Sox10)/+2274 | 14 | 86% | 14% | 0 | 0 | 0 |
| Sox10LacZ/+ | 23 | 39% | 61% | 0 | 0 | 0 |
| Sox10LacZ/+; Tg CF1-10 | 23 | 96% | 4% | 0 | 0 | 0 |
| Ednrbs/s | 5 | 0 | 0 | 100% | 0 | 0 |
| Ednrbs/s; Tg CF1-10 | 6 | 0 | 0 | 100% | 0 | 0 |
| Ednrbs/s–l | 9 | 0 | 0 | 0 | 100% | 0 |
| Ednrbs/s–l; Tg CF1-10 | 6 | 0 | 0 | 0 | 100% | 0 |
| Ednrbs–l/s–l | 1 | 0 | 0 | 0 | 0 | 100% |
| Ednrbs–l/s–l; Tg CF1-10 | 2 | 0 | 0 | 0 | 0 | 100% |
| Ednrbs/+ or Ednrbs–l/+ | 16 | 44% | 56% | 0 | 0 | 0 |
| Ednrbs/+; Tg CF1-10 or Ednrbs–l/+;Tg CF1-10 | 10 | 20% | 80% | 0 | 0 | 0 |
| Ednrbs–l/+ | 23 | 78% | 22% | 0 | 0 | 0 |
| Ednrbs–l/+; Sox10Dom/+ | 37 | 16% | 84% | 0 | 0 | 0 |
| Sox10Dom/+ | 14 | 7% | 93% | 0 | 0 | 0 |
No.:Number of animals used for the analysis
I: No hypopigmentation on dorsal or ventral surfaces
II: Ventral hypopigmentation only
III: Hypopigmentation over approximately 25% of the body surface area.
IV: Hypopigmentation over approximately 50 – 70% of the body surface area.
V: Hypopigmentation over approximately 95% of the body surface area.